# The Effect of Mobilized Stem Cell by G-CSF and VEGF Gene Therapy in Patients With Stable Severe Angina Pectoris

> **NCT00135850** · PHASE1,PHASE2 · COMPLETED · sponsor: **Rigshospitalet, Denmark** · enrollment: 48 (—)

## Conditions studied

- Ischemic Heart Disease

## Interventions

- **GENETIC:** VEGF-A165 plasmid

## Key facts

- **NCT ID:** NCT00135850
- **Lead sponsor:** Rigshospitalet, Denmark
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-03
- **Primary completion:** 2005-02
- **Final completion:** 2005-02
- **Target enrollment:** 48 (—)
- **Last updated:** 2011-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00135850

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00135850, "The Effect of Mobilized Stem Cell by G-CSF and VEGF Gene Therapy in Patients With Stable Severe Angina Pectoris". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT00135850. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*